UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000004259
Receipt number R000005110
Scientific Title Comparative study for glycemic control and adherence when adding DPP-4 inhibitor alogliptin to patients with type 2 diabetes who had been treated with three times administration of alpha-glucosidase inhibitors but still in poor glycemic control by maintaining, reducing, or stopping the administration of alpha-glucosidase inhibitors.
Date of disclosure of the study information 2010/10/01
Last modified on 2010/09/24 12:39:36

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Comparative study for glycemic control and adherence when adding DPP-4 inhibitor alogliptin to patients with type 2 diabetes who had been treated with three times administration of alpha-glucosidase inhibitors but still in poor glycemic control by maintaining, reducing, or stopping the administration of alpha-glucosidase inhibitors.

Acronym

alpha-GI0,1,2,3+alogliptin

Scientific Title

Comparative study for glycemic control and adherence when adding DPP-4 inhibitor alogliptin to patients with type 2 diabetes who had been treated with three times administration of alpha-glucosidase inhibitors but still in poor glycemic control by maintaining, reducing, or stopping the administration of alpha-glucosidase inhibitors.

Scientific Title:Acronym

alpha-GI0,1,2,3+alogliptin

Region

Japan


Condition

Condition

Type 2 Diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We compare glycemic control and adherence when adding 25 mg of DPP-4 inhibitor alogliptin to patients with type 2 diabetes who had been treated with three times administration of alpha-glucosidase inhibitors but still in poor glycemic control by maintaining, reducing (twice or once), or stopping the administration of alpha-glucosidase inhibitors.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase



Assessment

Primary outcomes

HbA1c, glycoalbumin

Key secondary outcomes

Body weight, adherence


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment

Numbered container method


Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Taking alogliptin only

Interventions/Control_2

Taking alpha-GI once a day in addition to alogliptin

Interventions/Control_3

Taking alpha-GI twice a day in addition to alogliptin

Interventions/Control_4

Taking alpha-GI thrice a day in addition to alogliptin

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1.Type 2 Diabetic patients
2.Patients who are taking alpha-GI thrice a day.
3.HbA1c <JDS> level at baseline 6.5-9.0%
4.Subjects who provided written informed consent.

Key exclusion criteria

1. Patients who are receiving insulin therapy.
2. Patients who are taking anti-diabetic medicines other than alpha-GI
3. Patients who have a severe hepatic dysfunction.
4. Patients who have a severe renal dysfunction
5. Patients whose doctor in charge judges as inappropriate for the inclusion

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yasuo Terauchi

Organization

Graduate School of Medicine, Yokohama City University

Division name

Department of Endocrinology and Metabolism

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama

TEL

045-787-2639

Email



Public contact

Name of contact person

1st name
Middle name
Last name Kiyomi Masuda

Organization

Graduate School of Medicine, Yokohama City University

Division name

Department of Endocrinology and Metabolism

Zip code


Address

3-9 Fukuura, Kanazawa-ku, Yokohama

TEL

045-787-2639

Homepage URL


Email

t086051a@yokohama-cu.ac.jp


Sponsor or person

Institute

Graduate School of Medicine, Yokohama City University

Institute

Department

Personal name



Funding Source

Organization

Graduate School of Medicine, Yokohama City University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

None

Name of secondary funder(s)

None


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

横浜市立大学附属病院(神奈川県)


Other administrative information

Date of disclosure of the study information

2010 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2010 Year 09 Month 03 Day

Date of IRB


Anticipated trial start date

2010 Year 10 Month 01 Day

Last follow-up date

2014 Year 09 Month 01 Day

Date of closure to data entry

2014 Year 09 Month 01 Day

Date trial data considered complete

2014 Year 09 Month 01 Day

Date analysis concluded

2014 Year 09 Month 01 Day


Other

Other related information



Management information

Registered date

2010 Year 09 Month 24 Day

Last modified on

2010 Year 09 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005110


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name